Expertise in
2
conditions

Eric De Kerviler

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Paris, FR 

Overview

Eric De Kerviler practices practicing medicine in Paris, France.

Mr. De Kerviler is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Febrile Neutropenia, Renal Cell Carcinoma (RCC), Non-Hodgkin Lymphoma, Prostatic Artery Embolization, and Nephrectomy.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Inria, Epione Team, 2004 Route Des Lucioles, Valbonne, 06902, France
Boulogne-billancourt, 92100, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Enrollment Status: Recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drugs: Oxaliplatin intravenous, 5 Fu, Folinic Acid, Oxaliplatin intra-arterial, Panitumumab, Bevacizumab
Study Phase: Phase 3
A Phase I Dose Escalation Trial Evaluating the Impact of an in Situ Immunization Strategy With Intra-Tumoral Injections of Pexa-Vec in Combination With Ipilimumab in Metastatic / Advanced Solid Tumors With Injectable Lesions.
A Phase I Dose Escalation Trial Evaluating the Impact of an in Situ Immunization Strategy With Intra-Tumoral Injections of Pexa-Vec in Combination With Ipilimumab in Metastatic / Advanced Solid Tumors With Injectable Lesions.
Enrollment Status: Completed
Publish Date: July 25, 2022
Intervention Type: Drug, Biological
Study Phase: Phase 1
View 1 Less Clinical Trial

59 Total Publications

Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia.
Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia.
Journal: PloS one
Published: October 14, 2024

Frequently Asked Questions about Eric De Kerviler

Is Eric De Kerviler a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Eric De Kerviler is classified as an Advanced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eric De Kerviler participate in research or clinical trials?

Yes. Eric De Kerviler has published 59 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Eric De Kerviler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Kerviler's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile